Self-reported side effects in children and adolescents taking risperidone

Simon Byrne, Garry Walter*, Glenn Hunt, Nerissa Soh, Michelle Cleary, Paul Duffy, Geoff Crawford, Peter Krabman, Patrick Concannon, Gin Malhi

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)


    Objective: We aimed to describe medication side effects in a cross-section of young people taking low-dose risperidone, using a self-report measure. Methods: The Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS) was completed by 66 patients aged between 6 and 18 years who had been taking low-dose risperidone (alone or in conjunction with other medications) for up to 13 years. Results: Young persons, overall, seemed to tolerate risperidone well, but longer exposure to the medication was associated with higher side effect levels, particularly for the psychic (pertaining to mind and emotion) and extrapyramidal subscales. The most common complaints related to psychic side effects, such as tiredness, difficulty concentrating, difficulty remembering things and increased dreaming. Conclusions: Clinicians need to monitor the side effects of young patients taking low doses of risperidone, and other psychotropics, and maintain vigilance in those who have been taking medication for extended periods.

    Original languageEnglish
    Pages (from-to)42-45
    Number of pages4
    JournalAustralasian Psychiatry
    Issue number1
    Publication statusPublished - 2010


    • Adolescents
    • Children
    • Liverpool University Neuroleptic Side Effect Rating Scale
    • Risperidone
    • Side effects


    Dive into the research topics of 'Self-reported side effects in children and adolescents taking risperidone'. Together they form a unique fingerprint.

    Cite this